Explore

Trendline Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Trendline Trendline
Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline
Trendline Trendline
Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate
Trendline Trendline
EyePoint Inc. Reports Increased Losses Amid Phase 3 Clinical Trials Funding

EyePoint Inc. Reports Increased Losses Amid Phase 3 Clinical Trials Funding

EyePoint Inc. Reports Increased Losses Amid Phase 3 Clinical Trials Funding
Trendline Trendline
Evommune Reports Q1 2026 Financial Results and Advances Inflammatory Disease Therapies

Evommune Reports Q1 2026 Financial Results and Advances Inflammatory Disease Therapies

Evommune Reports Q1 2026 Financial Results and Advances Inflammatory Disease Therapies
Trendline Trendline
Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments

Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments

Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments
Trendline Trendline
Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies

Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies

Silence Therapeutics Reports Q1 2026 Financial Results and Advances siRNA Therapies
Trendline Trendline
Viridian Therapeutics Raises $350 Million Through Convertible Notes and Stock Offerings

Viridian Therapeutics Raises $350 Million Through Convertible Notes and Stock Offerings

Viridian Therapeutics Raises $350 Million Through Convertible Notes and Stock Offerings
Trendline Trendline
Zura Bio Grants Inducement Awards to New Employees, Expanding Workforce

Zura Bio Grants Inducement Awards to New Employees, Expanding Workforce

Zura Bio Grants Inducement Awards to New Employees, Expanding Workforce
Trendline Trendline
Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market

Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market

Odyssey Therapeutics Sets Terms for $225 Million IPO Amid Resurgent Biotech Market
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026

Nuvectis Pharma Reports Increased Net Loss in Q1 2026